Charles River Laboratories Total Liabilities 2010-2024 | CRL

Charles River Laboratories total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Charles River Laboratories total liabilities for the quarter ending June 30, 2024 were $4.221B, a 6.5% decline year-over-year.
  • Charles River Laboratories total liabilities for 2023 were $4.593B, a 0.63% decline from 2022.
  • Charles River Laboratories total liabilities for 2022 were $4.622B, a 3.04% increase from 2021.
  • Charles River Laboratories total liabilities for 2021 were $4.485B, a 32.99% increase from 2020.
Charles River Laboratories Annual Total Liabilities
(Millions of US $)
2023 $4,593
2022 $4,622
2021 $4,485
2020 $3,373
2019 $3,055
2018 $2,536
2017 $1,883
2016 $1,873
2015 $1,331
2014 $1,195
2013 $989
2012 $983
2011 $1,031
2010 $1,045
2009 $830
Charles River Laboratories Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $4,221
2024-03-31 $4,507
2023-12-31 $4,593
2023-09-30 $4,296
2023-06-30 $4,515
2023-03-31 $4,586
2022-12-31 $4,622
2022-09-30 $4,750
2022-06-30 $4,876
2022-03-31 $4,460
2021-12-31 $4,485
2021-09-30 $4,626
2021-06-30 $4,397
2021-03-31 $3,621
2020-12-31 $3,373
2020-09-30 $3,312
2020-06-30 $3,484
2020-03-31 $3,546
2019-12-31 $3,055
2019-09-30 $3,046
2019-06-30 $3,167
2019-03-31 $2,526
2018-12-31 $2,536
2018-09-30 $2,540
2018-06-30 $2,681
2018-03-31 $1,858
2017-12-31 $1,883
2017-09-30 $1,841
2017-06-30 $1,807
2017-03-31 $1,818
2016-12-31 $1,873
2016-09-30 $1,817
2016-06-30 $1,927
2016-03-31 $1,319
2015-12-31 $1,331
2015-09-30 $1,324
2015-06-30 $1,180
2015-03-31 $1,180
2014-12-31 $1,195
2014-09-30 $1,169
2014-06-30 $1,188
2014-03-31 $953
2013-12-31 $989
2013-09-30 $984
2013-06-30 $971
2013-03-31 $973
2012-12-31 $983
2012-09-30 $968
2012-06-30 $981
2012-03-31 $1,001
2011-12-31 $1,031
2011-09-30 $1,044
2011-06-30 $1,115
2011-03-31 $1,180
2010-12-31 $1,045
2010-09-30 $1,042
2010-06-30 $763
2010-03-31 $803
2009-12-31 $830
2009-09-30 $842
2009-06-30 $871
2009-03-31 $870
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00